Education
About Us
Working with TipRanks
Follow Us
Instadose Pharma Corp (INSD)
:INSD
INSD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.24 - $0.25
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$532.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)$40.09K
Price to Earnings (P/E)―
Beta0.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding531,933,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
INSD FAQ
What was Instadose Pharma Corp’s price range in the past 12 months?
Instadose Pharma Corp lowest stock price was $0.24 and its highest was $0.25 in the past 12 months.
What is Instadose Pharma Corp’s market cap?
Instadose Pharma Corp’s market cap is $532.00.
When is Instadose Pharma Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Instadose Pharma Corp’s earnings last quarter?
Currently, no data Available
Is Instadose Pharma Corp overvalued?
According to Wall Street analysts Instadose Pharma Corp’s price is currently Overvalued.
Does Instadose Pharma Corp pay dividends?
Instadose Pharma Corp does not currently pay dividends.
What is Instadose Pharma Corp’s EPS estimate?
Instadose Pharma Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Instadose Pharma Corp have?
Instadose Pharma Corp has 531,933,800 shares outstanding.
What happened to Instadose Pharma Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Instadose Pharma Corp?
Currently, no hedge funds are holding shares in INSD
---
Company Description
Instadose Pharma Corp
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.
---
Technical Analysis
---